fbpx The Coming Equity Shortage - Ricardo Hausmann | Harvard Kennedy School

HKS Affiliated Authors


October 9, 2020, Opinion: "Firms that manage to survive until an effective COVID-19 vaccine is widely available will have a bright future but weak balance sheets. Innovative new private-equity funds, modeled on US special-purpose acquisition companies, could provide much-needed capital – not least in emerging markets."